More and more growing companies are looking at public markets as an alternative to raising another round of capital. For life science companies seeking to go public, foreign markets are often an a more attractive solution to the NASDAQ as they accept smaller companies, have lower compliance costs and quicker process. What does filing to go public in alternative markets mean for your company? What are advantages and disadvantages of different foreign exchanges?
Cori Gorman, Principal, DNA Bridges Gerald Turner, Partner, FOCUS Enterprises Inc. Jill Fujisaki, VP of Investor Relations, Entelos, Inc.
DISCLAIMER: Our aim is to continuously provide our
progressive audience with an open and interactive medium to view
and share relevant,
beneficial and interesting "career, economic, lifestyle and
networking" listings, ads, content and resources.
While the above information may be accurate and viable, the role
of Minority Professional Network, Inc. (MPN) is
strictly as a communications medium, and we do not
accept any responsibility for
cancellation, changes, errors, omissions, inconveniences, or any other form
of liability for any content
displayed or disseminated via our web sites, or e-marketing or social media
promotional services.
If there are any
doubts, we
encourage you to conduct additional research or contact the listed host or responsible entity.
CLICK HERE to inform us about any ads, listings or content
which appear to be
inappropriate,
fraudulent or misleading, or inconsistent with our theme and focus.